Amador Bioscience SRL
Amador Bioscience reported total assets of €1.22m at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Jun 2026).
The score of Amador Bioscience shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +354 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Amador Bioscience's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Jun 2026
- Year ended 31 Dec 2024filed on 01 Jun 2026
- Year ended 31 Dec 2023filed on 02 Oct 2024
- Year ended 31 Dec 2022filed on 02 Oct 2024
Amador Bioscience's financial analysis
- Solvency-191.5%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Amador Bioscience
Amador Bioscience's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0779.966.013
- VAT number
- BE0779966013
- Peppol
- Registered · 0208:0779966013 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Jan 2022
- Registered office
- 3500 Hasselt
- Latest accounts
- 2025 · filed on 21 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Amador Bioscience (SRL) has been based in Hasselt since 2022, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 267,760 € and equity of −€2.33m; its revenue is not published. Its solvency stands at -191.5%, below the median of its sector (60.4%).
Companies similar to Amador Bioscience
Companies in the same business, of comparable size and area, outside its group.
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- Drs Pipeleers & Marichal Research and experimental development on natural sciences and engineering Roosdaal · balance sheet €2.05m
- ProtonW.be Research and experimental development on natural sciences and engineering Charleroi · balance sheet €1.27m
- Nyemb Research and experimental development on natural sciences and engineering Tournai · balance sheet €1.15m
- myNeo Research and experimental development on natural sciences and engineering Ghent · balance sheet €2.21m
- Semaphar Research and experimental development on natural sciences and engineering Jodoigne · balance sheet 579,404 €
- Dokter Frankie Nobels Research and experimental development on natural sciences and engineering Dendermonde · balance sheet €1.87m
- Zomagen Biosciences Belgium Research and experimental development on natural sciences and engineering Ghent · balance sheet €1.83m
Frequently asked questions about Amador Bioscience
What is the revenue of Amador Bioscience?
Amador Bioscience files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Amador Bioscience?
In Belgium, the VAT number is the company number prefixed with BE: BE0779966013 for Amador Bioscience, if the company is VAT-registered. Its company number (CBE) is 0779.966.013.
Where is the registered office of Amador Bioscience?
According to the CBE register, the registered office of Amador Bioscience is in 3500 Hasselt.
What is the equity of Amador Bioscience?
At the close of the 2025 financial year, the equity of Amador Bioscience amounts to -2,329,065 €, a solvency of -191.5% of total assets.
Who manages Amador Bioscience?
The register lists 6 active mandates at Amador Bioscience. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Amador Bioscience
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →